Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Marek W Rajzer"'
Autor:
Justyna Siwy, Felix Keller, Mirosław Banasik, Björn Peters, Emmanuel Dudoignon, Alexandre Mebazaa, Dilara Gülmez, Goce Spasovski, Mercedes Salgueira Lazo, Marek W. Rajzer, Łukasz Fuławka, Magdalena Dzitkowska-Zabielska, Harald Mischak, Manfred Hecking, Joachim Beige, Ralph Wendt, UriCoV Working Group
Publikováno v:
Biomedicines, Vol 12, Iss 9, p 2090 (2024)
Background/Objectives: Survival prospects following SARS-CoV-2 infection may extend beyond the acute phase, influenced by various factors including age, health conditions, and infection severity; however, this topic has not been studied in detail. Th
Externí odkaz:
https://doaj.org/article/47ef4abafa0c4a669e5acc575fae59ac
Autor:
Maciej Skrzypek, Rafał Kolec, Michał Słaboszewski, Katarzyna Góra, Agnieszka Olszanecka, Piotr Wróbel, Katarzyna Stolarz-Skrzypek, Marek W. Rajzer
Publikováno v:
Journal of Cardiovascular Development and Disease, Vol 11, Iss 9, p 266 (2024)
Introduction: Chronic pain triggers a stress response, which results in increased blood pressure (BP). We investigated whether chronic low back pain (cLBP) in hypertensive patients is associated with an increased risk of hypertension-related organ da
Externí odkaz:
https://doaj.org/article/b5f46fd180414530bd934720615af22d
Autor:
Dries S. Martens, De-Wei An, Yu-Ling Yu, Babangida Sylvester Chori, Congrong Wang, Ana Inês Silva, Fang-Fei Wei, Chen Liu, Katarzyna Stolarz-Skrzypek, Marek W. Rajzer, Agnieszka Latosinska, Harald Mischak, Tim S. Nawrot, Jan Staessen
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8250e770240dc8e987ba9af2ea91c048
https://doi.org/10.2139/ssrn.4399159
https://doi.org/10.2139/ssrn.4399159
Autor:
Jan A Staessen, Ralph Wendt, Yu-Ling Yu, Sven Kalbitz, Lutgarde Thijs, Justyna Siwy, Julia Raad, Jochen Metzger, Barbara Neuhaus, Armin Papkalla, Heiko von der Leyen, Alexandre Mebazaa, Emmanuel Dudoignon, Goce Spasovski, Mimoza Milenkova, Aleksandra Canevska-Taneska, Mercedes Salgueira Lazo, Mina Psichogiou, Marek W Rajzer, Łukasz Fuławka, Magdalena Dzitkowska-Zabielska, Guenter Weiss, Torsten Feldt, Miriam Stegemann, Johan Normark, Alexander Zoufaly, Stefan Schmiedel, Michael Seilmaier, Benedikt Rumpf, Mirosław Banasik, Magdalena Krajewska, Lorenzo Catanese, Harald D Rupprecht, Beata Czerwieńska, Björn Peters, Åsa Nilsson, Katja Rothfuss, Christoph Lübbert, Harald Mischak, Joachim Beige, Lukasz Fulawka, Harald Rupprecht, Beata Czerwienska, Jörg Ermisch, Nils Kellner, Lydia Peruth-Stutzmann, Stefanie Schroth, Jonathan Schmidt, Ulrike Schmidt, Daniel Breuer, Fariza Abeud, Marie-Celine Fournier, Badr Louadah, Rocio Molas, Fraile Loreto Rojas, Fabiola Alonso García, Isabel Garcia Sánchez, Ioana Cezara Hrom, Andrzej Więczek., Matthias Schwab, Kei K Asayama, Tine W Hansen, Gladys E Maestre, Dimitrios Basoulis, Georgios Karamanakos., Pawel Lis, Agnieszka Olszanecka, Rosa Bellmann-Weiler, Lucas Lanser, Alicia Edin, Matthias NE Forsell, Bernd Stegmayr, Björn-Erik Ole Jensen, Hans-Martin Orth, Sylke Borstel, Agata Mikolajewska, Manfred Hecking, Lukas Schmölz, Michał Hoffmann, Krzysztof Narkiewicz, Agnieszka Matera-Witkiewicz, Justyna Zachciał, Monika Litwin, Patrycja Marciniak
BACKGROUND: The SARS-CoV-2 pandemic is a worldwide challenge. The CRIT-CoV-U pilot study generated a urinary proteomic biomarker consisting of 50 peptides (COV50), which predicted death and disease progression from SARS-CoV-2. After the interim analy
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3973ebe41317826f1bb3b476708a01e7
https://lirias.kuleuven.be/handle/20.500.12942/704971
https://lirias.kuleuven.be/handle/20.500.12942/704971
Autor:
MICHAL KANIA, KONRAD MAZUR, MICHAL TERLECKI, ZLATA CHAYKIVSKA, MATEUSZ K. FIEMA, MALGORZATA A. KOSTRZYCKA, MARIANNA KOPKA, MAGDALENA WILK, JERZY HOHENDORFF, TOMASZ KLUPA, PRZEMYSLAW W. WITEK, BARBARA KATRA, MAREK W. RAJZER, MACIEJ MALECKI
Publikováno v:
Diabetes. 71
Introduction: Diabetes is a risk factor for severe COVID-course. In this one-center report, we assessed clinical characteristics and risk factors associated with unfavorable outcomes in diabetic patients (DP) hospitalized due to COVID-19. Methods: We
Autor:
Jan Staessen, Ralph Wendt, Yu-Ling Yu, Sven Kalbitz, Lutgarde Thijs, Justyna Siwy, Julia Raad, Jochen Metzger, Barbara Neuhaus, Armin Papkalla, Heiko von der Leyen, Alexandre Mebazaa, Emmanuel Dudoignon, Goce Spasovski, Mimoza Milenkova, Aleksandra Canevska-Tanevska, Mina Psichogiou, Marek W. Rajzer, Lukasz Fulawka, Magdalena Dzitkowska-Zabielska, Günter Weiss, Torsten Feldt, Miriam Songa Stegemann, Johan Normark, Alexander Zoufaly, Stefan Schmiedel, Michael Seilmaier, Benedikt Rumpf, Miroslaw Banasik, Magdalena Krajewska, Lorenzo Catanese, Harald Rupprecht, Beata Czerwienska, Björn Peters, Asa Nilsson, Katja Rothfuss, Christoph Lübbert, Harald Mischak, Joachim Beige, CRIT-Cov-U Investigators
Publikováno v:
SSRN Electronic Journal.
Publikováno v:
Journal of Hypertension. 27:1102-1004